Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] Alteogen (196170) – Shinhan Securities | GSK Deal Supports Low Patent Risk View · Keytruda SC Royalty Calibrated · Target Price Adjusted / 2026-01-21 Research
  • [Research] Samsung Electronics (005930) – Kiwoom Securities | Strong 1Q26 Outlook · Full-Year Profit Forecast at KRW 172T · HBM Surge / 2026-01-30 Research
  • [Research] Samsung SDI (006400) – Kiwoom Securities | Quarterly Turnaround · ESS LFP Ramp-up · Europe EV Market Share / 2026-07-31 Research
  • [Research] LIG D&A (079550) – Daishin Securities | 2Q26 Review · Backlog Realization · Export Margin Expansion / 2026-08-10 Research
  • [Research] Samsung SDI (006400) – IBK Securities | Fully Booked North America ESS Expected · European IAA Benefits · 1Q Earnings Resilience / 2026-04-02 Research
  • [Research] Samsung Electronics (005930) – Eugene Investment & Securities | Memory Pricing Leverage · Supplier-Favorable Dynamics · Upward Forecast Revisions / 2026-01-09 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | FC-BGA CAPEX Expansion · Price Hikes · 2028F Forward Valuation / 2026-05-06 Research
  • [Research] Samsung Electronics (005930) – Kiwoom Securities | Memory ASP Upgrades · Full-Year Profit Raised to KRW 200T · Shipment Growth Cycle / 2026-03-03 Research

[Research] Samsung Electro-Mechanics (009150) – Shinhan Securities | AI Cycle · Capacity Utilization · Valuation Re-rating / 2026-04-09

Posted on 4월 9, 20268월 25, 2026 By ksb220805@gmail.com

Brokerage : Shinhan Securities

Analyst : Oh Kang-ho, Seo Ji-beom

Investment Rating : BUY (Maintained)

Target Price : KRW 700,000 (Raised)

Core Momentum : Structural earnings growth and valuation re-rating projected on the back of rising component capacity utilization and ASP expansion driven by the AI cycle

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: BUY maintained; Target Price raised by 40% to KRW 700,000 (Upside: 36.2%).
  • Valuation Methodology: Applied a target P/E multiple of 34.8x (a 15% premium over the 2023 peak P/E) to 2027F EPS of KRW 19,967 (+33% revision).
  • 1Q26 Earnings Preview:
    • Revenue: +12% YoY (revised estimate of KRW 3.0575 Trillion).
    • Operating Profit: KRW 268.7 Billion (+34% YoY; revised down 8.6% from previous estimate due to one-off expenses).
    • Operating Margin (OPM): Forecast at 8.8% (+1.5%p YoY).
    • Segment Revenue Growth: Component +12% YoY, Package Substrate +38% YoY.
  • Annual Financial Projections (2026F – 2028F):
    • 2026F: Revenue KRW 13.1617 Trillion (raised) / Operating Profit KRW 1.477 Trillion (raised) / Controlling Net Profit KRW 1.2314 Trillion (raised)
    • 2027F: Revenue KRW 14.9045 Trillion (raised) / Operating Profit KRW 1.9545 Trillion (raised) / Controlling Net Profit KRW 1.559 Trillion (raised)
    • 2028F: Revenue KRW 17.1008 Trillion / Operating Profit KRW 2.4436 Trillion / Controlling Net Profit KRW 1.9091 Trillion
  • Key Financial Multiples (2026F):
    • P/E: 32.6x (vs. Murata at 33.1x and substrate peer average at 57.7x)
    • P/B: 3.8x
    • ROE: 12.3%
    • EV/EBITDA: 13.2x
    • Dividend Yield (DY): 0.6%

🚀 2. [Market Opportunities & Business Outlook]

  • AI Cycle & Demand-Supply Dynamics:
    • Transition into a structural AI cycle with expanded intensity and timelines, creating a demand-outpacing-supply environment.
    • Growth driver transitioning from volume-driven (Q) to price-driven (P) expansion anchored by high-value product sales and ASP gains.
  • Component Division (MLCC):
    • Capacity utilization trend: 70% in 2023 → estimated ~93%+ in 2025 → projected ~95% in 2026.
    • Expanding mix of high-value products supporting expectations for continued Blended ASP improvements.
  • Package Solution Division (FC-BGA):
    • Rising Big Tech demand creating favorable conditions for broad-based pricing increases.
    • Maintaining outlook for stronger performance in the second half of the year (H2-heavy seasonality).
  • Global Valuation Re-rating:
    • Component and package substrate divisions collectively account for ~90% of total operating profit, justifying multiple expansion toward global peer levels (global substrate peer average P/E at ~58x).

📝 Editor’s Comment (Perspective)

The analyst views Samsung Electro-Mechanics not merely as a conventional components vendor subject to consumer IT hardware cycles, but as a premier global AI beneficiary capable of price-led (P) growth through rising utilization and high-value product mix upgrades. The underlying analytical thesis places greater strategic significance on sustaining mid-90% utilization rates in a tight demand-supply environment and the resulting pricing power across core component and substrate businesses, rather than short-term one-off cost impacts.

To assess whether this investment thesis continues to materialize, key tracking points include the Component division sustaining capacity utilization around 95%, the realization of second-half earnings acceleration in Package Solutions supported by Big Tech demand, and the extent to which AI-driven ASP expansion translates into achieving projected annual operating profit (KRW 1.47 Trillion+). These developments can be verified through upcoming quarterly earnings releases, official company IR presentations, periodic regulatory filings (quarterly and annual reports), and DART disclosures.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

글 탐색

Previous Post: [Research] Samsung Electronics (005930) – IBK Securities | Sustained Memory Pricing · LTA Demand · Quarterly Earnings Expansion / 2026-04-08
Next Post: [Research] SK hynix (000660 / SKHY) – Kiwoom | Server DRAM · eSSD · Earnings Upgrades / 2026-04-09

Related Posts

  • [Research] Samsung SDI (006400) – Mirae Asset Securities | SDC Stake Monetization Pursuit · North America ESS & Europe EV Order Acceleration · Operating Profit Turnaround / 2026-04-29 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Profit Turnaround · ESS Margin Support · North America LFP Ramp-up / 2026-07-20 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Long-term Exclusive Contracts · 2029 Target EPS · Structural ASP Hikes / 2026-06-01 Research
  • [Research] Samsung Electronics (005930) – Hana Securities | Memory Pricing · LTA Structure · Earnings Upward Revision / 2026-04-08 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | FC-BGA Seller’s Market · Full Capacity · Multiple Upward / 2026-01-26 Research
  • [Research] Samsung Biologics (207940) – Mirae Asset | Plant 5 Ramp-up · CDMO Expansion · Earnings Forecast / 2026-07-27 Research
  • [Research] Alteogen (196170) – Shinhan Securities | First UK Patent Ruling Favors Merck · Positive Read-across to Global Disputes · Pipeline Out-Licensing Ahead / 2026-02-23 Research
  • [Research] Samsung Electronics (005930) – Yuanta Securities | Strong 4Q25 Preliminary Earnings · 1Q26 Profit Momentum Maximization · Target Price Upgrade / 2026-01-08 Research
  • [IR] Samsung Electronics (005930) – Q2 2025 Earnings Presentation / 2025-07-31 IR Room
  • [Research] SK Telecom (017670 / SKM) – Daishin Securities | Wireless Rebound & Fixed-Line Peak · Launch of SK Hyper · 5GW AIDC Roadmap / 2026-08-06 Research
  • [Research] Samsung Electronics (005930) – IBK Securities | Memory ASP Surge · HBM4 Ramp-Up · Target Price Upgrade / 2026-07-08 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | 4Q Earnings Recovery · New Plant Ramp-up · Peptide Expansion / 2026-07-24 Research
  • [Research] ABL Bio (298380) – Kiwoom Securities | ABL301 Deprioritization · ABL001 Valuation · Grabody B Validity / 2026-02-02 Research
  • [Research] Samsung Electronics (005930) – iM Securities | Memory ASP Upgrades · Earnings Upward Revision · Iran War Variable / 2026-04-01 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme